E-LIB Suche - Ergebnisse für: Pour, Ludek

1

PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen ..:

Pour, Ludek ; Micheva, Ilina ; Usenko, Ganna...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. e267-e275.e2 , 2024

Link: https://doi.org/10.1016/..

2

Del(1p32) is an early and high-risk event in multiple myelo..:

Stork, Martin ; Ondrouskova, Eva ; Bohunova, Michaela...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Ixazomib plus daratumumab and dexamethasone: Final analysis..:

Delimpasi, Sosana ; Dimopoulos, Meletios A. ; Straub, Jan...
American Journal of Hematology. 99 (2024) 9 - p. 1746-1756 , 2024

Link: https://doi.org/10.1002/..

4

Health-related quality of life in relapsed/refractory multi..:

Schjesvold, Fredrik H. ; Ludwig, Heinz ; Delimpasi, Sossana...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

5

An open‐label, first‐in‐human, single agent, dose escalatio..:

Kapoor, Prashant ; Nathwani, Nitya ; Jelinek, Tomas...
European Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

6

Isatuximab plus carfilzomib–dexamethasone versus carfilzomi..:

Yong, Kwee ; Martin, Thomas ; Dimopoulos, Meletios-Athanasios...
The Lancet Haematology. , 2024

Link: https://doi.org/10.1016/..

7

Efficacy of ixazomib, lenalidomide, dexamethasone regimen i..:

Fric, Dominik ; Stork, Martin ; Boichuk, Ivanna...
European Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

8

A phase 1b/2 study evaluating efficacy and safety of MP0250..:

Knop, Stefan ; Szarejko, Monika ; Grząśko, Norbert...
eJHaem. , 2024

Link: https://doi.org/10.1002/..

9

Liquid biopsy of peripheral blood using mass spectrometry d..:

Vlachová, Monika ; Pečinka, Lukáš ; Gregorová, Jana...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

10

P-075 Real-world evidence on prognostic value of minimal re..:

Jelinek, Tomas ; Muronova, Ludmila ; Zihala, David...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S75-S76 , 2023

Link: https://doi.org/10.1016/..

11

P-159 Lenalidomide maintenance in R2-ISS stratified multipl..:

Radocha, Jakub ; Jungova, Alexandra ; Pour, Ludek...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S122-S123 , 2023

Link: https://doi.org/10.1016/..

12

Efficacy and safety of melflufen plus daratumumab and dexam..:

Pour, Luděk ; Szarejko, Monika ; Bila, Jelena...
Haematologica. 109 (2023) 3 - p. 895-905 , 2023

Link: https://doi.org/10.3324/..

13

Daratumumab with lenalidomide and dexamethasone in relapsed..:

Stork, Martin ; Spicka, Ivan ; Radocha, Jakub...
Annals of Hematology. 102 (2023) 6 - p. 1501-1511 , 2023

Link: https://doi.org/10.1007/..

14

Improved Screening of Monoclonal Gammopathy Patients by MAL..:

Pečinka, Lukáš ; Vlachová, Monika ; Moráň, Lukáš...
Journal of the American Society for Mass Spectrometry. 34 (2023) 12 - p. 2646-2653 , 2023

Link: https://doi.org/10.1021/..

15

Isatuximab in combination with cemiplimab in patients with ..:

Lesokhin, Alexander ; LeBlanc, Richard ; Dimopoulos, Meletios A....
Cancer Medicine. 12 (2023) 9 - p. 10254-10266 , 2023

Link: https://doi.org/10.1002/..